Latest News & Article News
USFDA successfully completes inspection at Indoco’s API manufacturing facility at Patalganga with zero observations
Indoco Remedies Limited announced today the successful completion…
By
ADMIN
Cohance Lifesciences API Unit-1 Clears USFDA Audit with Zero 483 Observations
Cohance Lifesciences proudly announced the successful completion of…
By
ADMIN
Amneal Submits BLA for XOLAIR® (Omalizumab) Biosimilar, Targets $4B U.S. Market
Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) has announced the…
By
ADMIN
Glenmark Partners with Hengrui for Global Rights to HER2-Targeting ADC Trastuzumab Rezetecan
Glenmark Specialty S.A. (GSSA), a wholly owned subsidiary…
By
ADMIN
Lupin Launches Liraglutide Injection in U.S. — USD 350 Million Market Opportunity
Global pharmaceutical major Lupin Limited (Lupin) has announced…
By
ADMIN
Intas Pharmaceuticals Announces Acquisition of Prothya Biosolutions Belgium BV
Intas Pharmaceuticals, through its subsidiary Accord Plasma B.V.,…
By
ADMIN
Biocon Opens Its First U.S. Manufacturing Facility in New Jersey to Bolster Access & Supply Resilience
Biocon Limited, an innovation-led global biopharmaceutical company, announced…
By
ADMIN
MS Pharma Hosts First Annual Biosimilar Summit to Advance Scientific Dialogue on Ophthalmic Biosimilars
As part of its strategic expansion in specialty…
By
Newspress
FDA Announces Completion of First AI-Assisted Scientific Review Pilot and Aggressive Agency-Wide AI Rollout Timeline
In a historic first for the agency, FDA…
By
Newspress
Odisha Attracts ₹4,349 Crore in Healthcare Investments at Make-in-Odisha Conclave 2025
The state of Odisha marked a significant milestone…
By
Newspress

India's DMPLOI - Jobs & Networking App